US 8546371
Nanoparticle formulated glycolipid antigens for immunotherapy
granted A61KA61K2039/55511A61K2039/55555
Quick answer
US patent 8546371 (Nanoparticle formulated glycolipid antigens for immunotherapy) held by The Board of Regents of the University of Texas System expires Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Oct 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2039/55511, A61K2039/55555, A61K2039/57, A61K39/39